Androgen insufficiency in women

Growth Hormone and IGF Research

Volumn 16, Issue SUPPL., 2006, Pages 109-117

  Braunstein, Glenn D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acne; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone sulfate; Female androgen insufficiency syndrome; Hirsutism; Hypoactive sexual desire disorder; Testosterone

Indexed keywords

ANDROGEN; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CORTICOSTEROID; DIETHYLSTILBESTROL; ESTRADIOL; ESTRADIOL VALERATE; ESTRATEST; ESTROGEN; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; METHYLDOPA; METHYLTESTOSTERONE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ACNE; AGGRESSION; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; BEHAVIOR DISORDER; BREAST CARCINOMA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CLITORIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ENDOMETRIUM HYPERPLASIA; FATIGUE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HAIR DISEASE; HIRSUTISM; HORMONE RELEASE; HUMAN; LARYNX DISORDER; LIBIDO DISORDER; LIVER DYSFUNCTION; MALIGNANT NEOPLASTIC DISEASE; PATIENT MONITORING; PELIOSIS HEPATIS; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TESTOSTERONE BLOOD LEVEL; VIRILIZATION; WELLBEING;

ANDROGENS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DRUG COMPOUNDING; DRUG EVALUATION; DRUG INDUSTRY; DRUG TOXICITY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; STATISTICS; STATISTICS AS TOPIC; SYNDROME; TESTOSTERONE; TREATMENT OUTCOME; WOMEN;

EID: 33746883605     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.03.009     Document Type: Article

References (74)

1. J.L. Shifren, National Disease and Therapeutic Index, IMS Health, 2003, presented at US Food and Drug Administration Reproductive Health Drugs Advisory Committee, December 2, 2004, Gaithersburg, MD.
2. Cameron D.R., and Braunstein G.D. Androgen replacement therapy in women. Fertil. Steril. 82 (2004) 273-289
3. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (1994), American Psychiatric Press, Washington, DC
4. Basson R., Berman J., Burnett A., et al. Report of the international consensus development conference of female sexual dysfunction: definitions and classifications. J. Urol. 163 (2000) 888-893
5. Laumann E.O., Nicolosi A., Glasser D.B., et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int. J. Impotence Res. 17 (2005) 39-57
6. Bancroft J., Sanders D., Davidson D., and Warner P. Mood, sexuality, hormones, and the menstrual cycle. III. Sexuality and the role of androgens. Psychosom. Med. 45 (1983) 509-516
7. Persky H., Lief A.I., Strauss D., Miller W.R., and O'Brien C.P. Plasma testosterone levels and sexual behavior of couple. Arch. Sex. Behav. 7 (1987) 157-173
8. Morris N.M., Udry J.D., Khan-Dawood F., and Dawood M.Y. Marital sexual frequency and midcycle female testosterone. Arch. Sex. Behav. 16 (1987) 27-38
9. Van Goozen S.H., Wiegant V.M., Endert E., Helmond F.A., and Van de Poll N.E. Psychoendocrinological assessment of the menstrual cycle: the relationship between hormones, sexuality, and mood. Arch. Sex. Behav. 26 (1997) 359-382
10. Riley A., and Riley E. Controlled studies on women presenting with sexual drive disorder. I. Endocrine status. J. Sex Marital. Ther. 26 (2000) 269-283
11. Floter A., Nathorst-Boos J., Carlstrom B.K., and von Schoultz B. Androgen status and sexual life in perimenopausal women. Menopause 4 (1997) 95-100
12. Persky H., Dreisbach L., Miller W.R., et al. The relation of plasma androgen levels to sexual behaviors and attitudes of women. Psychosom. Med. 44 (1982) 305-319
13. McCoy N.L., and Davidson J.M. A longitudinal study of the effects of menopause on sexuality. Maturitas 7 (1985) 203-210
14. Dennerstein L., Randolph J., Taffe J., Dudley E., and Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil. Steril. 77 (2002) S42-S48
15. Bachmann G.A., Leiblum S.R., Kemmann E., Colburn D.W., Swartzman L., and Shelden R. Sexual expression and its determinants in the post-menopausal woman. Maturitas 6 (1984) 19-29
16. Cutler W.B., Garcia C.R., Huggins G.R., and Preti G. Sexual behavior and steroid levels among gynecologically premature premenopausal women. Fertil. Steril. 48 (1986) 496-502
17. Schreiner-Engel P., Schiavi R.C., White D., and Ghizzani A. Low sexual desire in women: the role of reproductive hormones. Horm. Behav. 23 (1989) 221-234
18. Bancroft J., Sherwin B., Alexander G.M., Davidson D.W., and Walker A. Oral contraceptives, androgens, and the sexuality of young women. II. The role of androgens. Arch. Sex. Behav. 20 (1991) 121-135
19. Cawood E.H., and Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psycholog. Med. 26 (1996) 925-936
20. Studd J.W., Collins W.P., Chakravarti S., Newton J.R., Oram D., and Parsons A. Oestradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal woman. Br. J. Obstet. Gynaecol. 84 (1977) 314-315
21. Dennerstein L., Dudley E.C., Hopper J.L., and Burger H. Sexuality, hormones and the menopausal transition. Maturitas 26 (1997) 83-93
22. Appelt H., and Strauss B. Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism. Psychother. Psychosomat. 42 (1984) 177-181
23. Braunstein G.D., Sundwall D.A., Katz M., et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. A randomized, placebo-controlled trial. Arch. Intern. Med. 165 (2005) 1582-1589
24. Buster J.E., Kingsberg S.A., Aguirre O., et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet. Gynecol. 105 (2005) 944-952
25. Simon J., Braunstein G., Nachtigall L., et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab. 90 (2005) 5226-5233
26. Bachmann G., Bancroft J., Braunstein G.D., et al. Female androgen insufficiency: the Princeton Consensus Statement on definition, classification, and assessment. Fertil. Steril. 77 (2002) 660-665
27. Miller K.K., Sesmilo G., Schiller A., Schoenfeld D., Burton S., and Klibanski A. Androgen deficiency in women with hypopituitarism. J. Clin. Endocrinol. Metab. 86 (2001) 51-57
28. Arlt W., Callies F., van Vlijmen J.C., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341 (1999) 1013-1020
29. Hughes C.L., Wall L.L., and Creasman W.T. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol. Oncol. 40 (1991) 42-45
30. Judd H.L., Lucas W.E., and Yen S.S. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am. J. Obstet. Gynecol. 118 (1974) 793-798
31. Gravholt C.H., Svenstrup B., Bennett P., and Christiansen J.S. Reduced androgen levels in adult Turner syndrome: influence of female sex steroids and growth hormone status. Clin. Endocrinol. 50 (1999) 791-800
32. Hartmann B.W., Kirchengast S., Albrecht A., Laml T., Soregi G., and Huber J.C. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecolog. Obstet. Invest. 44 (1997) 127-131
33. Hunt P.J., Gurnell E.M., Huppert F.A., et al. Improvement in mood and fatigue after dehydroepiandrosterone treatment in Addison's disease in a randomized double-blind trial. J. Clin. Endocrinol. Metab. 85 (2000) 4650-4656
34. Lovas K., Gabre-Medhin G., Trovik T.S., et al. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J. Clin. Endocrinol. Metab. 88 (2003) 1112-1118
35. Abraham G.E. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J. Clin. Endocrinol. Metab. 39 (1974) 340-346
36. Laughlin G.A., Barrett-Connor E., Kritz-Silverstein D., and von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85 (2000) 645-651
37. Vehkavaara S., Hakala-Ala-Pietilä T., Virkamaki A., et al. Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation 102 (2000) 2687-2693
38. Simon J.A. Estrogen replacement therapy: effects on endogenous androgen milieu. Fertil. Steril. 77 (2002) S77-S82
39. Greenblatt R.B., Warfield W.E., Garner J.F., Calk G.L., and Harrod J.P. Evaluation of estrogen, androgen, and estrogen-androgen combination and a placebo in the treatment of menopause. J. Clin. Endocrinol. Metab. 10 (1950) 1547-1558
40. Dow M.G., and Hart D.M. Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br. J. Obstet. Gynaecol. 90 (1983) 361-366
41. Burger H.G., Hailes J., Menelaus M., Nelson J., Hudson B., and Balazs N. The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 6 (1984) 351-358
42. Sherwin B.B., Gelfand M.M., and Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sexual steroid administration in the surgical menopause. Psychosom. Med. 47 (1985) 339-351
43. Sherwin B.B., and Gelfand M.M. Differential symptoms response to parenteral estrogen and/or androgen administration in the surgical menopause. Am. J. Obstet. Gynecol. 151 (1985) 153-159
44. Sherwin B.B., and Gelfand M. The role of androgen in the maintenance of sexual functioning in ovarectomized women. Psychosom. Med. 49 (1987) 397-409
45. Burger H., Hailes J., and Nelson J. Effect of combined implants of oestradiol and testosterone on libido in post-menopausal women. Br. Med. J. 294 (1987) 936-937
46. Myers L.S., Dixen J., Morrissette D., Carmichael M., and Davidson J.M. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 70 (1990) 1124-1131
47. Davis S.R., McCloud P., Strauss B.J., and Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21 (1995) 227-236
48. Tuiten A., Laan E., Panhuysen G., et al. Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychosom. Med. 58 (1996) 234-241
49. Sarrel P., Dobay B., and Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. J. Reprod. Med. 43 (1998) 847-856
50. Shifren J.L., Braunstein G.D., Simon J.A., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med. 343 (2000) 682-688
51. Floter A., Nathorst-Boos K., Carlstrom K., and Schoultz B. Addition of testosterone to estrogen replacement in oophorectomized women: effects on sexuality and well-being. Climacteric 5 (2002) 357-365
52. Davis S., Rees M., Ribot C., Moufarege A., Rodenberg C., and Purdie D. Efficacy and safety of testosterone patches for the treatment of low sexual desire in surgically menopausal women. Fertil. Steril. 80 Suppl. 3 (2003) S76 (abstract O-199)
53. Lobo R.A., Rosen R.C., Yang H.M., Block B., and van der Hoop R.G. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil. Steril. 79 (2003) 1341-1352
54. Goldstat R., Briganti E., Tran J., Wolfe R., and Davis S.R. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 10 (2003) 390-398
55. Warnock J.K., Swanson S.G., Borel R.W., Zipfel L.M., Brennan J.J., and and the ESTRATEST Clinical Study Group. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Menopause 12 (2005) 374-384
56. Kirschner M.A. Hirsutism and virilism in women. Special Top. Endocrinol. Metab. 6 (1984) 55-93
57. Rosenfield R.L. Pilosebaceous physiology in relation to hirsutism and acne. Clin. Endocrinol. Metab. 15 (1986) 341-362
58. Meyer W.J., Webb A., Stuart C.A., Finkelstein J.W., Lawrence B., and Walker P.A. Physical and hormonal evaluation of transsexual patients: a longitudinal study. Arch. Sex. Behav. 15 (1986) 121-138
59. Basaria S., and Dobs A.S. Safety and adverse effects of androgens: how to counsel patients. Mayo Clin. Proc. 79 Suppl. (2004) S25-S32
60. van Kesteren P.J., Asscheman H., Megens J.A., and Gooren L.J. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin. Endocrinol. 47 (1997) 337-342
61. Futterweit W., and Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J. Clin. Endocrinol. Metab. 62 (1986) 16-21
62. Somboonporn W., and Davis S.R. Testosterone effects on breast: implications for testosterone therapy for women. Endocr. Rev. 25 (2004) 374-388
63. Dimitrakakis C., Zhou J., Wang J., et al. A physiological role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10 (2003) 292-298
64. Dimitrakakis C., Jones R.A., Liu A., and Bondy C.A. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 11 (2004) 531-535
65. Burgess H.W., and Shousha S. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynecomastia. J. Pathol. 170 (1993) 37-43
66. North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause 12 (2005) 497-511
67. Taieb J., Mathian B., Millot F., et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin. Chem. 49 (2003) 1381-1395
68. Gruschke A., and Kuhl H. Validity of radioimmunological methods for determining free testosterone in serum. Fertil. Steril. 76 (2001) 576-582
69. Ferriman D., and Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21 (1961) 1440-1447
70. Lorenzo E.M. Familial study of hirsutism. J. Clin. Endocrinol. Metab. 31 (1970) 556-564
71. Palatsi R., Hirvensalo E., Liukko P., et al. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives. Acta Derm. Venereol. 64 (1984) 517-523
72. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 326 (2003) 45-47
73. Moynihan R. The marketing of a disease: female sexual dysfunction. BMJ 330 (2005) 192-194
74. Greenblatt R.B. Androgenic therapy in women. Endocrinology 2 (1942) 665-666